🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
Summary Objective: The aim of this study is to determine the effect of heal...
Status
Completed
Location
University of Health Sciences
Start Date
2021-06-15
Trial ID
NCT05676021
Treatments Being Tested
To assess the safety, tolerance, and steady-state pharmacokinetics of multi...
Status
Completed
Location
ViRx Inc
Start Date
TBD
Trial ID
NCT00002338
Treatments Being Tested
SHARP-P is an observational cohort study investigating the effect of direct...
Status
Completed
Location
NSW Correctional Centres
Start Date
2019-09-06
Trial ID
NCT03740906
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
To prove that a study drug is noninferior to a control drug with a proporti...
Status
Completed
Location
Severance Hospital of Yonsei University
Start Date
2015-07
Trial ID
NCT02792088
Treatments Being Tested
This open-label study will evaluate the safety, pharmacokinetics and antivi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01638650
Treatments Being Tested
SHARP-C is an observational cohort study investigating the effect of direct...
Status
Completed
Location
St Vincent's Hospital
Start Date
2018-08-17
Trial ID
NCT03343925
Persistent viral infection with viral reservoirs and detection of circulati...
Status
Active Not Recruiting
Location
UCSF/Zuckerberg San Francisco General Hospital
Start Date
2024-04-09
Trial ID
NCT06161688
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested